Verrica Pharmaceuticals Correlations
VRCA Stock | USD 0.69 0.01 1.43% |
The current 90-days correlation between Verrica Pharmaceuticals and ESSA Pharma is -0.13 (i.e., Good diversification). The correlation of Verrica Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Verrica Pharmaceuticals Correlation With Market
Significant diversification
The correlation between Verrica Pharmaceuticals and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Verrica |
Moving together with Verrica Stock
0.7 | EQ | Equillium | PairCorr |
0.66 | ME | 23Andme Holding | PairCorr |
0.74 | VALN | Valneva SE ADR | PairCorr |
0.76 | DOMH | Dominari Holdings | PairCorr |
0.7 | DRMA | Dermata Therapeutics | PairCorr |
0.62 | DRRX | Durect | PairCorr |
0.73 | DTIL | Precision BioSciences | PairCorr |
0.61 | VIGL | Vigil Neuroscience | PairCorr |
0.66 | VINC | Vincerx Pharma | PairCorr |
0.7 | VKTX | Viking Therapeutics | PairCorr |
0.69 | VTGN | VistaGen Therapeutics | PairCorr |
Moving against Verrica Stock
0.73 | DVAX | Dynavax Technologies | PairCorr |
0.72 | VCEL | Vericel Corp Ord | PairCorr |
0.66 | VCYT | Veracyte | PairCorr |
0.66 | SABSW | SAB Biotherapeutics | PairCorr |
0.59 | CDIOW | Cardio Diagnostics | PairCorr |
0.55 | DSGN | Design Therapeutics | PairCorr |
0.54 | DRTS | Alpha Tau Medical | PairCorr |
0.54 | DYAI | Dyadic International | PairCorr |
0.44 | DMAC | DiaMedica Therapeutics | PairCorr |
0.38 | DRUG | Bright Minds Biosciences | PairCorr |
0.37 | VERA | Vera Therapeutics | PairCorr |
0.36 | SRZNW | Surrozen Warrant | PairCorr |
0.76 | VRNA | Verona Pharma PLC | PairCorr |
0.66 | VTRS | Viatris Sell-off Trend | PairCorr |
0.64 | ELDN | Eledon Pharmaceuticals | PairCorr |
0.59 | KTTAW | Pasithea Therapeutics | PairCorr |
0.57 | VSTM | Verastem | PairCorr |
0.56 | ENSC | Ensysce Biosciences Trending | PairCorr |
0.53 | VYNE | Vyne Therapeutics | PairCorr |
0.52 | ELTX | Elicio Therapeutics | PairCorr |
0.5 | ELUT | Elutia Inc | PairCorr |
0.42 | VTVT | vTv Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Verrica Stock performing well and Verrica Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Verrica Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ORIC | 2.82 | (0.43) | 0.00 | (0.15) | 0.00 | 5.15 | 20.53 | |||
LYRA | 4.44 | (0.52) | 0.00 | (0.39) | 0.00 | 10.53 | 41.07 | |||
INBX | 1.90 | (0.17) | 0.00 | (0.40) | 0.00 | 4.72 | 11.96 | |||
EPIX | 3.77 | (1.13) | 0.00 | 2.08 | 0.00 | 5.37 | 84.25 | |||
SNSE | 6.73 | 0.37 | 0.04 | (1.40) | 7.43 | 11.11 | 110.76 | |||
NXTC | 2.87 | (0.65) | 0.00 | (4.22) | 0.00 | 5.43 | 24.13 | |||
NUVB | 3.46 | (0.05) | 0.01 | 0.02 | 4.42 | 9.48 | 21.30 | |||
GLUE | 5.29 | 0.67 | 0.15 | 0.23 | 4.41 | 8.40 | 103.72 | |||
DSGN | 3.98 | 0.31 | 0.06 | 0.15 | 5.67 | 8.54 | 33.11 | |||
ERAS | 3.31 | (0.02) | 0.00 | 0.03 | 3.53 | 7.42 | 20.29 |
Verrica Pharmaceuticals Corporate Management
Eugene Scavola | Executive Operations | Profile | |
Terence Kohler | Chief Officer | Profile | |
Dr MBA | Head Development | Profile | |
Christopher Hayes | Secretary, Officer | Profile | |
Joe Bonaccorso | Chief Commercial Officer | Profile | |
Gary MD | Chief Officer | Profile |